Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)
| 1.50 Delayed Data As of May 20 |  -0.01 / -0.66%Today’s Change | 1.29 Today|||52-Week Range 8.50 | -68.42% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 29.4M | 47.7M | 12.8M | 22.5M | |
| Short Term Investment Cash | 26.7M | 18.4M | -34.9M | 9.6M | ||
| Cash & Short Term Investments | 33.1M | 63.5M | 50.3M | 74.5M | ||
| Receivables | Receivables | 1.7M | 1.2M | 3.1M | 300.0K | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 912.0K | 1.7M | 1.6M | 1.9M | |
| Current Assets | 35.8M | 66.4M | 55.0M | 76.7M | ||
| Total Assets | Property, Plant and Equipment - Gross | 456.0K | 839.0K | 1.3M | 1.8M | |
| Depreciation | -108.0K | -240.0K | -487.0K | -752.0K | ||
| Other Assets | 2.6M | 40.0K | 232.0K | 50.0K | ||
| Total Assets | 38.7M | 67.1M | 56.1M | 77.7M | ||
| Liabilities | Accounts Payable | 176.0K | 168.0K | 389.0K | 663.0K | |
| Accrued Expenses | 1.8M | 2.5M | 3.4M | 6.9M | ||
| Other Current Liabilities | 1.8M | 2.5M | 3.4M | 6.9M | ||
| Other Liabilities | 2.5M | 4.0M | 5.6M | 10.2M | ||
| Total Liabilities | Other Liabilities | 27.0K | 132.0K | 111.0K | 72.0K | |
| Total Liabilities | 2.6M | 4.1M | 5.7M | 10.3M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 58.3M | 0.00 | 0.00 | 0.00 | ||
| Common Equity | -22.2M | 63.0M | 50.3M | 67.4M | ||
| Total Shareholder Equity | 36.1M | 63.0M | 50.3M | 67.4M | ||
| Share Information | Common Shares Outstanding | 13.7M | 13.4M | 16.7M | 24.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
